Effect of timing and duration of azithromycin therapy of leptospirosis in a hamster model

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 1, 2007, Pages 148-151

  Moon, James E ^a   Rivard, Robert G ^a   Griffith, Matthew E ^a   Ressner, Roseanne A ^a   McCall, Suzanne ^a   Reitstetter, Raven E ^a   Hospenthal, Duane R ^a   Murray, Clinton K ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

Animal model; Prophylaxis; Treatment

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOEQUIVALENCE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TREATMENT FAILURE; FEMALE; HAMSTER; LEPTOSPIRA; LEPTOSPIROSIS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIPLE CYCLE TREATMENT; NONHUMAN; REPEATED DRUG DOSE; SHORT COURSE THERAPY; SURVIVAL RATE; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CRICETINAE; DOXYCYCLINE; FEMALE; LEPTOSPIROSIS; MESOCRICETUS; TIME FACTORS;

EID: 33845900931     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl453     Document Type: Article

References (15)

1. Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14: 296-326.
2. Suputtamongkol Y, Niwattayakul K, Suttinont C et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 2004; 39: 1417-24.
3. Joshi N, Miller DQ. Doxycycline revisited. Arch Intern Med 1997; 157: 1421-8.
4. Jain R, Danziger LH. The macrolides antibiotics: A pharmacokinetic and pharmacodynamic overview. Curr Pharm Des 2004; 10: 3045-53.
5. Murray CK, Hospenthal DR. Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique. Antimicrob Agents Chemother 2004; 48: 4002-5.
6. Moon JE, Ellis MW, Griffith ME et al. Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. Antimicrob Agents Chemother 2006; 50: 1989-92.
7. Takafuji ET, Kirkpatrick JW, Miller RN et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 310: 497-500.
8. Murray CK, Hospenthal DR. Broth microdilution susceptibility testing for Leptospira spp. Antimicrob Agents Chemother 2004; 48: 1548-52.
9. Faine S, Kaipainen WJ. Erythromycin in experimental leptospirosis. J Infect Dis 1955; 97: 146-51.
10. Cook AR, Thompson PE. The effects of oleandomycin, erythromycin, carbomycin, and penicillin G on Leptospira icterohaemorrhagiae in vitro and in experimental animals. Antibiot Chemother 1957; 7: 125-7.
11. Truccolo J, Charavay F, Merien F et al. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother 2002; 46: 848-53.
12. Elwell MR, Ward GS, Hansukjariya P et al. Doxycycline prophylaxis for experimental Leptospira infection in non-human primates and hamsters. Southeast Asian J Trop Med Public Health 1985; 16: 268-73.
13. Alexander AD, Rule PL. Penicillins, cephalosporins, and tetracyclines in treatment of hamsters with fatal leptospirosis. Antimicrob Agents Chemother 1986; 30: 835-9.
14. Bosnar M, Kelneric Z, Munic V et al. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother 2005; 49: 2372-7.
15. Fitzgeorge RB, Featherstone AS, Baskerville A. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophilia by aerosol. J Antimicrob Chemother 1990; 25 Suppl A: 101-8.